Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia

Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia

Introduction Deutetrabenazine is approved for treatment of Huntington disease (HD)-related chorea and tardive dyskinesia (TD) in adults. Factors associated with deutetrabenazine persistence and adherence are not well understood. Methods Claims data from the Symphony Health Solutions Integrated Datav...

Full description

Bibliographic Details
Main Authors: Claassen Daniel O. MD, Ayyagari Rajeev PhD, García-Horton Viviana PhD, Zhang Su PhD, Leo Sam PharmD
Format: Article
Language:English
Published: American Association of Psychiatric Pharmacists 2023-10-01
Series:Mental Health Clinician
Subjects:
deutetrabenazine
adherence
persistence
tardive dyskinesia
chorea
huntington disease
Online Access:https://theijpt.org/doi/pdf/10.9740/mhc.2023.10.207

Internet

https://theijpt.org/doi/pdf/10.9740/mhc.2023.10.207

Similar Items